FDA Grants Full Approval for Pfizer-BioNTech Covid-19 Vaccine
August 25, 2021
WASHINGTON - The Food and Drug Administration (FDA) on Monday granted full approval of the Pfizer-BioNTech Covid-19 vaccine. It is the first Covid-19 vaccine to receive the designation from the FDA.
For the unvaccinated, the Pfizer-BioNTech Covid-19 vaccine is now available for all Americans over the age of 16 years, including American Indians and Alaska Natives (AI/ANs). The vaccine continues to be available under emergency use authorization for Native youth ages 12-15 years and certain immunocompromised persons who are receiving a third dose.
Leading medical experts hope the full-approval designation from the FDA will convince those who have been vaccine hesitant to receive the vaccine.